The identification of protein modules that recognize the broad spectrum of modifications present on histone proteins is critical for understanding how chromatin dynamics influence fundamental nuclear processes^[@R6]^. The BAH domain is an evolutionarily conserved chromatin-associated motif^[@R7]^. In budding yeast, the BAH domain of the silencing regulator Sir3 was shown to be a nucleosome-binding domain^[@R8]--[@R10]^, suggesting that other BAH domains might function as chromatin-effector modules. To test this hypothesis, we screened several BAH domains from yeast and human for binding activity on peptide microarrays containing 82 modified and unmodified histone peptides, including 54 uniquely methylated peptides ([Supplementary Fig. 1](#SD2){ref-type="supplementary-material"})^[@R11]^. The BAH domain of human ORC1^[@R12]^ (hORC1~BAH~: amino acids 1 -- 185) bound with high specificity to H4K20me2 peptides ([Fig. 1a](#F1){ref-type="fig"}). In peptide pull-down assays, hORC1~BAH~ bound H4K20me2 peptides, but did not interact with several other dimethylated histone peptides ([Fig. 1b](#F1){ref-type="fig"}). In addition, hORC1~BAH~ did not interact with unmodified H4 peptide, and showed a strong preference for H4K20me2 over H4K20me1 or H4K20me3 ([Fig. 1c](#F1){ref-type="fig"}). Quantitation of the interaction by isothermal titration calorimetry (ITC) demonstrated that hORC1~BAH~ bound to H4(14-25)K20me2 peptides with a *K*~d~ of 5.2 µM, whereas monomethylation and trimethylation at K20 reduced the binding affinity five- (*K*~d~ = 24.8 µM) and eight- (*K*~d~ = 40.0 µM) fold, respectively ([Fig. 1d](#F1){ref-type="fig"}). Finally, hORC1~BAH~ bound to full-length H4K20me2 that is present in bulk-purified histones ([Fig. 1e](#F1){ref-type="fig"}). Together, these *in vitro* results demonstrate that hORC1~BAH~ binds with high specificity and affinity to H4K20me2.

ORC1 is an evolutionarily conserved protein, found in virtually all eukaryotes^[@R2],[@R12]^. As shown in [Figure 1f](#F1){ref-type="fig"}, H4K20me2 recognition is a common activity of BAH domains of ORC1 from several different metazoans. In contrast, the BAH domains of ORC1 from yeast *S. cerevisiae* (scORC1~BAH~) and *S. pombe* lack H4K20me2-binding activity. In both of these yeast species, it is known that ORC binds directly to DNA sequences at origins of replication, whereas in metazoans, chromatin plays a more significant role in directing ORC to replication origins^[@R2],[@R13],[@R14]^.

To understand the molecular basis of ORC1 BAH domain recognition of H4K20me2, the crystal structure of the complex between H4(14-25)K20me2 peptide and the BAH domain of mouse ORC1(9-170) (mORC1~BAH~) was solved at 1.95 Å resolution ([Fig. 2a](#F2){ref-type="fig"}; crystallization statistics in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). mORC1~BAH~ adopts a characteristic BAH-domain fold ([Fig. 2a](#F2){ref-type="fig"}), as first reported for the scORC1~BAH~^[@R15]^. Complex formation between H4(14-25)K20me2 and mORC1~BAH~ is mediated by van der Waals contacts, hydrogen-bonding and electrostatic interactions ([Fig. 2b--c](#F2){ref-type="fig"}). The dimethylammonium group of H4K20me2 is anchored by cation-π interactions with the side chains of an aromatic cage located at the mORC1~BAH~ surface and composed of Tyr63, Trp87, Tyr114 and Trp119, and the dimethylammonium proton is hydrogen-bonded to the side chain of Glu93 ([Fig. 2d](#F2){ref-type="fig"}), similar to H4K20me2 bound to the 53BP1 Tudor domain^[@R16]^ ([Supplementary Fig. 2](#SD2){ref-type="supplementary-material"}). The aromatic cage in mORC1~BAH~ is absent in the published structure of *sc*ORC1~BAH~ ([Supplementary Fig. 3](#SD2){ref-type="supplementary-material"})^[@R15]^, explaining why *sc*ORC1~BAH~ does not bind H4K20me2 ([Fig. 1f](#F1){ref-type="fig"}).

The preference of hORC1~BAH~ for H4K20me2 over its me1/3 counterparts (see [Fig. 1c](#F1){ref-type="fig"}) likely reflects the contribution from the hydrogen bond formed between the dimethylammonium proton and the side chain carboxylate of Glu93 ([Fig. 2c](#F2){ref-type="fig"}). Indeed, previous studies demonstrated that a single Tyr-to-Glu substitution within an otherwise aromatic cage of the BPTF PHD finger reverses the binding preference from trimethyl- to dimethyllysine^[@R17]^. Engineering a binding preference for H4K20me1 likely would require incorporation of a second carboxylate group to line the aromatic cage of hORC1~BAH~ and facilitate hydrogen bond formation with both monomethylammonium protons. The high degree of specificity of mORC1~BAH~ for the sequence surrounding H4K20 is conferred by a series of intermolecular hydrogen-bonding interactions involving Lys16, His18, Val21, and Arg23 of the bound peptide and residues lining the peptidebinding channel of mORC1~BAH~ ([Fig. 2b--c](#F2){ref-type="fig"}). While backbone-backbone interactions represent the majority of contacts, a water-mediated hydrogen bond involving the imidazole ring of His18, as well as a salt bridge between Lys16 of the H4 peptide and Glu126 of mORC1~BAH~ are also observed ([Fig 2b--c](#F2){ref-type="fig"}). In this regard, acetylation at K16 slightly reduced the binding affinity of hORC1~BAH~ and mORC1~BAH~ for the H4K16acK20me2 peptide ([Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}).

To investigate the structural dynamics of H4K20me2 binding, we determined the 1.70 Å crystal structure of mORC1~BAH~ in the free state (crystallization statistics in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). Superimposition of the mORC1~BAH~ structures in the free and peptide-bound states demonstrated that while the interaction with H4K20me2 does not alter the conformation for the majority of the protein, the K20me2-binding pocket of mORC1~BAH~ undergoes a significant rearrangement upon complex formation ([Fig. 2e](#F2){ref-type="fig"}; [Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}). Specifically, formation of the mORC1~BA~H-H4K20me2 complex prompts the indole ring of Trp119, which in the free state stacks with the indole ring of Trp87, to swing aside and accommodate insertion of H4K20me2 ([Fig. 2e](#F2){ref-type="fig"}). In addition, the interaction elicits reorientation of Glu93 to allow its side chain to hydrogen bond with the methylammonium proton of H4K20me2 ([Fig. 2e](#F2){ref-type="fig"}).

ITC studies establish that mORC1~BAH~ binds to H4K20me2 peptide with a *K*~d~ of 9.6 µM, with the binding affinity towards H4K20me1 and H4K20me3 weaker by a factor of 2 to 3 (*K*~d~ = 32.7 µM and 17.4 µM, respectively ([Supplementary Fig. 6a](#SD2){ref-type="supplementary-material"})). The mORC1~BAH~ domain shows moderate sequence conservation through evolution, with relatively high conservation of residues lining the H4K20me2-binding pocket ([Supplementary Fig. 6b](#SD2){ref-type="supplementary-material"}); hORC1~BAH~ retains all the aromatic cage residues that recognize H4K20me2, except for Trp119 of mORC1~BAH~, which is substituted by Cys120 in hORC1~BAH~. Replacing mORC1~BAH~Trp119 with a cysteine (human counterpart) resulted in increased discrimination of H4K20me2 over H4K20me3 from two-fold to three-fold, approaching the eight-fold discrimination observed for hORC1~BAH~ ([Supplementary Fig. 6a](#SD2){ref-type="supplementary-material"}). However, given that this mutant could not fully recapitulate the H4K20me2-binding specificity of hORC1~BAH~ ([Supplementary Fig. 6a](#SD2){ref-type="supplementary-material"}), other residues likely contribute to H4K20me2 discrimination. Indeed a C120A substitution in hORC1~BAH~ decreases binding to all three methylation states of H4K20me, with retention of H4K20me2-specificity ([Supplementary Fig. 6a](#SD2){ref-type="supplementary-material"}).

ITC analysis also demonstrated that alanine substitutions of the remaining residues lining the H4K20me2-binding pocket of hORC1~BAH~ (Y64A, W88A, E94A, and Y115A) abolished or largely diminished H4K20me2 recognition ([Fig. 2f](#F2){ref-type="fig"}). Similar results were observed with hORC1~BAH~ and mORC1~BAH~ cage mutants in peptide-binding assays ([Fig. 2g](#F2){ref-type="fig"}; [Supplementary Fig. 6c](#SD2){ref-type="supplementary-material"}) and in histone-binding assays ([Fig. 2h](#F2){ref-type="fig"}). These results further support the structural analysis and establish the molecular basis for the H4K20me2-ORC1~BAH~ interaction.

H4K20me2 is an abundant H4 modification^[@R18]^, and the BAH domain of ORC1, while dispensable for ORC complex assembly, has been shown to be important for loading of the complex onto chromatin in humans cells^[@R19]^. We therefore postulated that the interaction between ORC1 and H4K20me2 might regulate ORC stabilization at chromatin. First, ORC components (ORC2, ORC3 and ORC5) affinity purified with two structure-guided H4K20me2-binding mutants (hORC1~Y64A~ and hORC1~W88A~) with an efficiency equal to that observed with the wild-type protein in both U2OS ([Fig. 3a](#F3){ref-type="fig"}) and HT1080 ([Supplementary Fig. 7a](#SD2){ref-type="supplementary-material"}) cell lines, suggesting that H4K20me2 binding by ORC1 is dispensable for ORC complex assembly. Next, analysis of lysates biochemically separated into chromatin-enriched and soluble fractions from cells stably expressing hORC1, hORC1~Y64A~, or hORC1~W88A~ demonstrated that hORC1~Y64A~ and hORC1~W88A~ enrichment at chromatin was considerably reduced in comparison to hORC1 ([Fig. 3b](#F3){ref-type="fig"}; [Supplementary Fig. 7b](#SD2){ref-type="supplementary-material"}). Moreover, chromatin association of the ORC components ORC2, ORC3, ORC5 and ORC6 was compromised in cells expressing the ORC1 H4K20me2-binding pocket mutants ([Fig. 3c](#F3){ref-type="fig"}; [Supplementary Fig. 7c](#SD2){ref-type="supplementary-material"}). Thus, hORC1~BAH~ binding to H4K20me2 is required for efficient stabilization of ORC1 and other ORC components at chromatin.

Local chromatin structure is thought to play a role in the mechanism that determines metazoan origins of replication^[@R13]^. In this context, chromatin immunoprecipitation (ChIP) assays with a highly specific H4K20me2 antibody in G1 synchronized U2OS cells ([Supplementary Figs. 8--9](#SD2){ref-type="supplementary-material"}) demonstrated enrichment of H4K20me2 signal at two defined human replication origins^[@R20]--[@R23]^ relative to adjacent sequences ([Fig. 3d](#F3){ref-type="fig"}; [Supplementary Fig. 10](#SD2){ref-type="supplementary-material"}). Moreover, like the pattern of H4K20me2, hORC1 occupancy peaked at origins relative to adjacent sequences ([Fig. 3e](#F3){ref-type="fig"}; [Supplementary Fig. 10](#SD2){ref-type="supplementary-material"}). In contrast, hORC1~Y64A~ and hORC1~W88A~ enrichment at origins was not observed, even though the H4K20me2 peak at origins is present in these cell lines ([Figs. 3de](#F3){ref-type="fig"}; [Supplementary Fig. 10](#SD2){ref-type="supplementary-material"}). These data suggest that H4K20me2 may play a role at human origins by stabilizing ORC1 at chromatin.

ORC marks genomic origins of replication during the G1 phase of the cell cycle and serves to nucleate assembly of the pre-DNA replication complex (pre-RC) to coordinate DNA replication during S phase^[@R14]^. As a core component of this licensing machinery, ORC1 is required for efficient cell-cycle progression and the transition from G1 to S phase^[@R4],[@R19]^. In this context, cell-cycle analysis demonstrated a decreased S phase population and a lower S/G1 ratio in WI38 primary fibroblast transiently expressing the H4K20me2-binding mutants hORC1~Y64A~ and hORC1~W88A~ relative to wild-type hORC1-overexpressing cells ([Fig. 3f](#F3){ref-type="fig"}). Notably, mouse embryonic fibroblast isolated from mice lacking the enzymes that generate H4K20me2 (Suv4-20h1 and Suv4-20h2) show DNA replication defects, including delayed S-phase entry^[@R18]^. Thus, ORC1 recognition of the canonical H4K20me2 mark appears to facilitate ORC chromatin loading to promote DNA replication and cell-cycle progression.

Mutations in components of the pre-DNA replication machinery, including ORC1, have recently been identified in individuals with MGS, and in a zebrafish model, *orc1* morphants display an MGS-like proportionate dwarfism phenotype^[@R3],[@R4],[@R24]^. In MGS individuals, the majority of *ORC1* mutations fall within the protein's BAH domain^[@R3],[@R4]^, including two mutants (F89S and E127G) that are in regions that impinge upon H4K20me2 recognition ([Fig. 4a](#F4){ref-type="fig"}) and decrease binding of hORC1~BAH~ to H4K20me2 peptides ([Figs. 4b--c](#F4){ref-type="fig"}). Furthermore, mice deficient in H4K20me2 synthesis are born significantly smaller than control littermates^[@R18]^. Together, these observations implicate disruption of the ORC1-H4K20me2 interaction in MGS pathogenesis. To test this hypothesis, an *orc1* zebrafish morphant reconstitution system was established. Injection of two independent *orc1*-targeting morpholino oligonucleotides (MO) resulted in growth retardation, recapitulating published results^[@R4]^ ([Fig. 4d--e](#F4){ref-type="fig"}; data not shown). Co-injection of *hORC1* mRNA with zebrafish *orc1*-targeting MOs attenuated the dwarf phenotype observed in the *orc1* morphant alone ([Fig. 4d--e](#F4){ref-type="fig"}). In contrast, co-injection of *hORC1~Y64A~* and *hORC1~W88A~* mRNA failed to rescue *orc1* morphants, moderately aggravating the growth retardation phenotype ([Fig. 4d--e](#F4){ref-type="fig"}).

The H4K20me2/3 lysine methyltransferases (KMTs) Suv4-20h1 and Suv4-20h2 are conserved in zebrafish^[@R25]^. As shown in [Figure 4f](#F4){ref-type="fig"}, injection of MOs targeting *Danio rario suv4-20h1* and *suv4-20h2* resulted in global depletion of H4K20me2 and H4K20me3, and an increase in H4K20me1; these changes in H4K20 methylation are similar to those observed in cells derived from *Suv4-20h1/20h2* double knockout mice^[@R18]^. Analysis of body size in the *suv4-20h1/20h2* morphants demonstrated that H4K20me2 depletion results in a significant dwarfism phenotype compared to controls ([Fig. 4g--h](#F4){ref-type="fig"}). Finally, *orc1/suv4-20h1/20h2* morphants did not display significantly more dwarfisms than *orc1* or *suv4-20h1/20h2* morphants ([Supplementary Fig. 11](#SD2){ref-type="supplementary-material"}). Together, these data argue that the specific recognition of H4K20me2 by the BAH domain of ORC1 plays a crucial role in determining organism body size.

In summary, we have identified the BAH domain as a novel methyllysine-binding module, demonstrating that H4K20me2 recognition is an evolutionarily conserved function for BAH domains from diverse metazoan ORC1 proteins. These results provide the first direct link between histone methylation and the metazoan DNA replication machinery. The mechanism that determines metazoan origins of replication is thought to be dependent upon both the information encoded in the DNA sequence at origins, as well as the local chromatin architecture^[@R13],[@R14]^. Several histone modifications have been detected at origins^[@R20]--[@R22],[@R26],[@R27]^, including H3K27me1, which regulates replication of DNA at heterochromatin in *Arabidopsis*^[@R28]^. The mark H4K20me1 is present in early G1 at human origins and likely serves as the chromatin template for H4K20me2 catalysis^[@R18],[@R29],[@R30]^. Since H4K20me1 is generated in a highly cell-cycle regulated manner by the KMT PR-Set7/SET8, this modification may regulate licensing by governing the temporal and spatial availability of H4K20me2 at origins^[@R29]^. We postulate that the recognition of H4K20me2 by ORC1 cooperates with other ORC chromatin-loading mechanisms in marking replication origins. Based on this model, during developmental phases requiring rapid cell division, inefficient pre-RC formation due to abrogation of the ORC1-H4K20me2 interaction would result in delayed cell-cycle progression and insufficient cellular proliferation, a characteristic of proportional "hypocellular" dwarfism disorders like MGS^[@R5]^. Together, our findings reveal a new function for histone methylation signaling at chromatin in the regulation of DNA replication and organismal growth.
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![The ORC1 BAH domain is a novel H4K20me2-binding module\
**a,** hORC1~BAH~ preferentially binds H4K20me2 peptides. Microarrays spotted with 82 distinct histone peptides as indicated in [Supplementary Fig. 1](#SD2){ref-type="supplementary-material"} were probed with glutathione S-transferase (GST) fused to human ORC1 amino acids (aa) 1-185 (hORC1~BAH~). Red spots indicate positive binding. **b and c,** hORC1~BAH~ specifically binds H4K20me2 peptides. Western blot analysis of histone peptide pull-downs with GST-hORC1~BAH~ and the indicated biotinylated peptides. **d,** hORC1~BAH~ binds with highest affinity to H4K20me2. ITC was used to determine the dissociation constants (*K*~d~s) for the interaction of hORC1~BAH~ with the indicated peptides: H4K20me1 (green diamonds), H4K20me2 (red squares) and H4K20me3 (blue triangles). Standard deviation (s.d.) was derived from nonlinear fitting. **e,** hORC1~BAH~ binds full-length H4K20me2. Top: Western blot of GST-hORC1~BAH~ and GST control pull-downs from calf thymus histones (CTH) with the indicated antibodies. Bottom: Coomassie blue stain of input (20% of total). **f,** H4K20me2 binding is a common property of ORC1 BAH domains from diverse metazoan species. Binding assays as in (b) with GST-fused ORC1 BAH domains from the indicated species and using the indicated peptides.](nihms358243f1){#F1}

![The molecular basis of H4K20me2 recognition by ORC1~BAH~\
**a--c,** 1.95 Å crystal structure of murine ORC1 BAH aa 9-170 (mORC1~BAH~) complexed with H4(14-25)K20me2 peptide. **a,** Ribbon representation of mORC1~BAH~ bound to H4K20me2 peptide. The mORC1~BAH~ (cyan) and the bound H4K20me2 peptide (yellow) are shown in ribbon and stick representations, respectively. **b,** Details of intermolecular contacts in the mORC1~BAH~-H4K20me2 complex. mORC1~BAH~ and H4K20me2 peptide residues are colored in pink and yellow, respectively, with hydrogen bonds depicted as red dashed lines, and a water molecular as a red sphere. **c,** Schematic representation of intermolecular contacts in the mORC1~BAH~-H4K20me2 complex. The residues from the H4K20me2 peptide and mORC1~BAH~ are colored in magenta and black, respectively. Yellow: the hydrophobic contact. **d,** Positioning of the K20me2 side chain within an aromatic cage of the indicated residues (red) on the surface of mORC1~BAH~. The equivalent cage residues in hORC1~BAH~ are labeled in parenthesis. **e,** Structural overlay of the mORC1~BAH~ K20me2-binding aromatic cage in the free (silver) and H4K20me2-bound states (salmon). Arrows indicate binding-induced structural shifts. **f,** Mutations in the hORC1~BAH~ H4K20me2-binding channel impair H4K20me2 recognition. ITC analysis of the indicated hORC1~BAH~ mutants binding to H4K20me2 peptide; s.d. derived from non-linear fitting. **g--h,** Mutations in the hORC1~BAH~ dimethyllysine-binding cage abrogate H4K20me2 recognition. **g,** Binding assays as in ([Fig. 1b](#F1){ref-type="fig"}) with the indicated hORC1~BAH~ mutant proteins and biotinylated peptides. **h,** Top: Western analysis of CTH binding assays as in ([Fig. 1e](#F1){ref-type="fig"}) with the indicated proteins and antibodies. Bottom: Coomassie blue stain of input GST-fusion proteins and histones (20% of total).](nihms358243f2){#F2}

![ORC1-H4K20me2 interaction regulates ORC chromatin association and cell cycle progression\
**a,** Western blot analysis with the indicated antibodies of wild-type (WT) and H4K20me2-binding pocket mutants (Y64A and W88A) affinity-purified FLAG-tagged ORC1 complexes from U2OS cells. Control, empty vector control IP. WCE, whole cell extract. **b,** The ORC1~BAH~-H4K20me2 interaction is required for efficient ORC1 chromatin association. Western blot analysis of lysates biochemically separated into chromatin-enriched and soluble fractions from U2OS cells stably expressing the indicated ORC1 protein. Quantitation of FLAG-ORC1 levels is shown. Control, empty vector control lysates. Tubulin and H3 levels are shown as control for the integrity of fractionation. **c,** Disruption of ORC1 binding to H4K20me2 destabilizes ORC chromatin association. Western blot analysis of biochemically purified chromatin from U2OS cells as in (b) with the indicated antibodies. Total ORC protein levels in WCE are shown. **d,** H4K20me2 is enriched at DNA replication origins. H4K20me2 signal normalized to total H4 at the MCM4 origin and indicated flanking regions in G1 phase synchronized U2OS cells stably expressing the indicated ORC protein; *y*-axis: H4K20me2 ChIP/H4 ChIP. **e,** An intact BAH domain is required for ORC1 occupancy at replication origins. Occupancy of FLAG tagged hORC1, hORC1~Y64A~, hORC1~W88A~, or control was determined by ChIP analysis (*y*-axs: % input) as in (d). Error bars in (d, and e,) indicate s.e.m. from three experiments. **f,** The ORC1-H4K20me2 interaction is required for efficient cell cycle progression. The cell-cycle profile of WI38 cells transiently expressing GFP and the indicated ORC1 protein was determined by flow cytometry. GFP-positive cells were used to ensure that only transfected cells were analyzed. (Left) Percentage of cells in the indicated cell-cycle phase is shown. (Right) The S/G1 ratio for the indicated transfections is shown. Error bars indicate s.d. from two experiments.](nihms358243f3){#F3}

![Disruption of the ORC1~BAH~-H4K20me2 interaction leads to dwarfism in zebrafish\
**a--c,** MGS-associated mutations F89S and E127G impair H4K20me2 binding by hORC1. **a,** Close-up view of mORC1~BAH~ bound to H4K20me2, with residues F88 and E126 (equivalent to F89 and E127 in hORC1, respectively) shown in stick representation. **b,** ITC analysis as in ([Fig. 1d](#F1){ref-type="fig"}) of F89S and E127G hORC1 ~BAH~ mutants binding to H4K20me2 peptides. \*ITC data for wild-type hORC1~BAH~ from [Fig. 1d](#F1){ref-type="fig"}. **c,** Binding assays as in ([Fig. 1b](#F1){ref-type="fig"}) with the indicated hORC1~BAH~ mutant proteins and biotinylated peptides. **d--e,** The H4K20me2-recognition activity of hORC1 is required to rescue the dwarfism phenotype of *orc1* morphants. **d,** Quantification of dwarf phenotype in zebrafish injected with morphilino oligos (MO) targeting the *orc1* translation start site (tss) alone or MO co-injected with the indicated *hORC1* mRNAs. Insert on left shows electrophoresis analysis of the indicated *hORC1* mRNAs used for reconstitution. Control, uninjected embryos. Dwarfism was defined as a reduction of body length of ≥ 3 s.d. relative to the average size of the control zebrafish. Zebrafish analyzed: control: 26; *orc1* MO: 86; MO+*hORC1~WT~*: 67; MO+*hORC1~Y64A~*: 85; MO+*hORC1~W88A~*: 83. *P* values are calculated with a two-tailed unpaired Student's *t*-test. \*\* *P* \< 0.01. **e,** Representative images of zebrafish in (b) 1 day post-fertilization (dpf). **f,** Depletion of H4K20me2/3 in *suv4-20h1/suv4-20h2* morphants. Western blot analysis using the indicated antibodies of whole animal extracts 1 dpf from control zebrafish or zebrafish injected with MOs targeting the tss's of *suv4-20h1* and *suv4-20h2*. Control, uninjected embryos. **g--h,** Dwarfism in *suv4-20h1/suv4-20h2* morphants. **g,** Quantification of dwarfism in *suv4-20h1/suv4-20h2* morphants relative to controls as described in (d). Zebrafish analyzed: control: 38; MO: 60. \*\* *P*\<0.01. **h,** representative images of zebrafish in (e) 1 dpf.](nihms358243f4){#F4}
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